Monogram Orthopaedics, Inc. (NASDAQ:MGRM - Free Report) - Equities researchers at Zacks Small Cap issued their Q3 2025 EPS estimates for Monogram Orthopaedics in a report released on Thursday, March 13th. Zacks Small Cap analyst T. Kerr anticipates that the company will post earnings of ($0.11) per share for the quarter. The consensus estimate for Monogram Orthopaedics' current full-year earnings is ($0.49) per share.
Several other analysts also recently weighed in on MGRM. Roth Capital set a $5.40 price objective on Monogram Orthopaedics in a report on Tuesday. Roth Mkm lifted their price objective on Monogram Orthopaedics from $4.00 to $5.40 and gave the company a "buy" rating in a report on Tuesday.
Check Out Our Latest Analysis on Monogram Orthopaedics
Monogram Orthopaedics Stock Down 6.5 %
Shares of MGRM stock traded down $0.24 on Friday, hitting $3.43. The stock had a trading volume of 1,824,627 shares, compared to its average volume of 286,006. The business has a 50 day moving average price of $2.56 and a 200 day moving average price of $2.49. The company has a market cap of $121.04 million, a PE ratio of -7.30 and a beta of 1.66. Monogram Orthopaedics has a one year low of $1.53 and a one year high of $4.90.
Monogram Orthopaedics (NASDAQ:MGRM - Get Free Report) last released its quarterly earnings data on Wednesday, March 12th. The company reported ($0.08) earnings per share for the quarter, beating the consensus estimate of ($0.11) by $0.03.
Hedge Funds Weigh In On Monogram Orthopaedics
Large investors have recently added to or reduced their stakes in the company. Jane Street Group LLC bought a new position in Monogram Orthopaedics in the fourth quarter worth about $25,000. Barclays PLC bought a new position in Monogram Orthopaedics in the third quarter worth about $29,000. Wells Fargo & Company MN raised its holdings in Monogram Orthopaedics by 286.6% in the fourth quarter. Wells Fargo & Company MN now owns 11,597 shares of the company's stock worth $27,000 after purchasing an additional 8,597 shares in the last quarter. Orion Portfolio Solutions LLC bought a new position in Monogram Orthopaedics in the fourth quarter worth about $31,000. Finally, State Street Corp bought a new position in Monogram Orthopaedics in the third quarter worth about $62,000. 0.45% of the stock is currently owned by institutional investors.
About Monogram Orthopaedics
(
Get Free Report)
Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.
Recommended Stories
Before you consider Monogram Orthopaedics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Monogram Orthopaedics wasn't on the list.
While Monogram Orthopaedics currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
